{"title":"持续专业发展","authors":"","doi":"10.1111/ceo.13770","DOIUrl":null,"url":null,"abstract":"2. Which of the following statements for the Fight Retinal Blindness! Registry is correct? a. The registry collects data of clinical trials in macular therapeutics. b. It records data of only Australian patients receiving VEGF inhibitors for AMD. c. It is an international database that tracks treatment outcomes of macular diseases in routine clinical practice. d. The registry records grant available for research in macular diseases.","PeriodicalId":15372,"journal":{"name":"Journal of Clinical & Experimental Ophthalmology","volume":"21 1","pages":"541 - 543"},"PeriodicalIF":0.0000,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Continuing Professional Development\",\"authors\":\"\",\"doi\":\"10.1111/ceo.13770\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"2. Which of the following statements for the Fight Retinal Blindness! Registry is correct? a. The registry collects data of clinical trials in macular therapeutics. b. It records data of only Australian patients receiving VEGF inhibitors for AMD. c. It is an international database that tracks treatment outcomes of macular diseases in routine clinical practice. d. The registry records grant available for research in macular diseases.\",\"PeriodicalId\":15372,\"journal\":{\"name\":\"Journal of Clinical & Experimental Ophthalmology\",\"volume\":\"21 1\",\"pages\":\"541 - 543\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical & Experimental Ophthalmology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/ceo.13770\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical & Experimental Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/ceo.13770","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

2. 以下哪项是对抗视网膜失明的声明?注册表正确吗?a.注册中心收集黄斑治疗的临床试验数据。b.仅记录了澳大利亚接受VEGF抑制剂治疗AMD患者的数据。c.这是一个跟踪黄斑疾病在常规临床实践中的治疗结果的国际数据库。d.登记记录了用于黄斑疾病研究的资助。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Continuing Professional Development
2. Which of the following statements for the Fight Retinal Blindness! Registry is correct? a. The registry collects data of clinical trials in macular therapeutics. b. It records data of only Australian patients receiving VEGF inhibitors for AMD. c. It is an international database that tracks treatment outcomes of macular diseases in routine clinical practice. d. The registry records grant available for research in macular diseases.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Tuesday 1 March Speakers Film Abstracts Monday 28 February Speakers Sunday 27 February Speakers Modification of Biochemical Derangements and VEGF Secretion May Prevent Diabetic Retinopathy (DR): An Advance Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1